Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04427072
Title Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation (GeoMETry-III)
Acronym GeoMETry-III
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD | ITA | FRA | ESP | DEU | BRA | BEL

Facility Status City State Zip Country Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Sao Paulo SP 04014-002 Brazil Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Pierre Benite 69495 France Details
Novartis Investigative Site Gauting Bayern 82131 Germany Details
Novartis Investigative Site Koeln 50937 Germany Details
Novartis Investigative Site New Delhi Delhi 110076 India Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Roma RM 00128 Italy Details
Novartis Investigative Site Seoul 05505 Korea, Republic of Details
Novartis Investigative Site Nijmegen 6500 HB Netherlands Details
Novartis Investigative Site Matosinhos 4454 513 Portugal Details
Novartis Investigative Site Valencia Comunidad Valenciana 46026 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field